Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing

Prenatal Diagnosis

Volumn 32, Issue 4, 2012, Pages 389-395

  Mcgillivray, George ^a,b   Rosenfeld, Jill A ^c   Mckinlay Gardner, R J ^d,e   Gillam, Lynn H ^b,f  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c PERKINELMER INC   (United States)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MICROARRAY ANALYSIS; COPY NUMBER VARIATION; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MEDICAL ETHICS; MEDICAL INFORMATION; MICROARRAY ANALYSIS; PATIENT AUTONOMY; PREGNANCY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; CHOICE BEHAVIOR; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA COPY NUMBER VARIATIONS; FEMALE; GENETIC COUNSELING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MORAL OBLIGATIONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATIENT PREFERENCE; PATIENT RIGHTS; PHYSICIANS; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT; UNCERTAINTY;

EID: 84859112155     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3849     Document Type: Article

References (79)

1. Shuster E. Microarray genetic screening: a prenatal roadblock for life? Lancet 2007;369(9560):526-9.
2. Friedman JM. High-resolution array genomic hybridization in prenatal diagnosis. Prenat Diagn 2009;29(1):20-8.
3. Grody WW. Ethical ramifications of genetic analysis using DNA arrays. Methods Mol Biol (Clifton, NJ). 2001;170:53-69.
4. Leroi AM. The future of neo-eugenics. Now that many people approve the elimination of certain genetically defective fetuses, is society closer to screening all fetuses for all known mutations? EMBO Rep 2006;7(12):1184-7.
5. Pergament E. Controversies and challenges of array comparative genomic hybridization in prenatal genetic diagnosis. Genetics In Medicine: Official Journal of the American College of Medical Genetics. 2007;9(9):596-9.
6. Schaaf CP, Wiszniewska J, Beaudet AL. Copy number and SNP arrays in clinical diagnostics. Annu Rev Genomics Hum Genet 2011;12:25-51.
7. Fruhman G, Van den Veyver IB. Applications of array comparative genomic hybridization in obstetrics. Obstet Gynecol Clin North Am 2010;37(1):71-85, Table of Contents.
8. Savage MS, Mourad MJ, Wapner RJ. Evolving applications of microarray analysis in prenatal diagnosis. Curr Opin Obstet Gynecol 2011;23(2):103-8.
9. Ballif BC, Rorem EA, Sundin K, et al. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A 2006;140(24):2757-67.
10. Hoang S, Ahn J, Mann K, et al. Detection of mosaicism for genome imbalance in a cohort of 3042 clinical cases using an oligonucleotide array CGH platform. Eur J Med Genet 2011;54(2):121-9.
11. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86(5):749-64.
12. Alkan C, Coe BP, Eichler EE. Genome structural variation discovery and genotyping. Nat Rev Genet 2011;12(5):363-76.
13. Bruno DL, White SM, Ganesamoorthy D, et al. Pathogenic aberrations revealed exclusively by single nucleotide polymorphism (SNP) genotyping data in 5000 samples tested by molecular karyotyping. J Med Genet 2011;48(12):831-9.
14. Conlin LK, Thiel BD, Bonnemann CG, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis. Hum Mol Genet 2010;19(7):1263-75. [Epub 2010 Jan]
15. Manning M, Hudgins L, Professional P, et al. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genetics in Medicine: Official Journal of the American College of Medical Genetics. 2010;12(11):742-5.
16. Hochstenbach R, van Binsbergen E, Engelen J, et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36, 325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet 2009;52(4):161-9.
17. Sagoo GS, Butterworth AS, Sanderson S, et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13, 926 subjects. Genetics in Medicine: Official Journal of the American College of Medical Genetics. 2009;11(3):139-46.
18. Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010;125(4):e727-35.
19. Coppinger J, Alliman S, Lamb AN, et al. Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray. Prenat Diagn 2009;29(12):1156-66.
20. Faas BHW, van der Burgt I, Kooper AJA, et al. Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250k SNP array analysis. J Med Genet 2010;47(9):586-94.
21. Kleeman L, Bianchi DW, Shaffer LG, et al. Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn 2009;29(13):1213-7.
22. Maya I, Davidov B, Gershovitz L, et al. Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat Diagn 2010;30(12-13):1131-7.
23. Shaffer LG, Coppinger J, Alliman S, et al. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn 2008;28(9):789-95.
24. Tyreman M, Abbott KM, Willatt LR, et al. High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. J Med Genet 2009;46(8):531-41.
25. Van den Veyver IB, Patel A, Shaw CA, et al. Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 2009;29(1):29-39.
26. Vialard F, Molina Gomes D, Leroy B, et al. Array comparative genomic hybridization in prenatal diagnosis: another experience. Fetal Diagn Ther 2009;25(2):277-84.[Epub 2009 Jun].
27. Hillman SC, Pretlove S, Coomarasamy A, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011;37(1):6-14.
28. Hehir-Kwa JY, Wieskamp N, Webber C, et al. Accurate distinction of pathogenic from benign CNVs in mental retardation. PLoS Comput Biol 2010;60(4):e1000752.
29. Leung TY, Pooh RK, Wang CC, et al. Classification of pathogenic or benign status of CNVs detected by microarray analysis. Expert Rev Mol Diagn 2010;10(6):717-21.
30. Ben-Shachar S, Lanpher B, German JR, et al. Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet 2009;46(6):382-8.
31. Hannes FD, Sharp AJ, Mefford HC, et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009;46(4):223-32.
32. Mefford HC, Sharp AJ, Baker C, et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008;359(16):1685-99.
33. Sharp AJ, Mefford HC, Li K, et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008;40(3):322-8.
34. Ullmann R, Turner G, Kirchhoff M, et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 2007;28(7):674-82.
35. Bruno DL, Stark Z, Amor DJ, et al. Extending the scope of diagnostic chromosome analysis: detection of single gene defects using high-resolution SNP microarrays. Hum Mutat 2011;32(12):1500-6.
36. Garcia-Casado Z, Romero I, Fernandez-Serra A, et al. A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. BMC Med Genet 2011;12:134.
37. Shchelochkov OA, Cheung SW, Lupski JR. Genomic and clinical characteristics of microduplications in chromosome 17. Am J Med Genet A 2010;152A(5):1101-10.
38. Schaaf CP, Scott DA, Wiszniewska J, et al. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet 2011;377(9765):555-6.
39. Sahoo T, Cheung SW, Ward P, et al. Prenatal diagnosis of chromosomal abnormalities using array-based comparative genomic hybridization. Genetics in Medicine: Official Journal of the American College of Medical Genetics. 2006;8(11):719-27.
40. Leung TY, Vogel I, Lau TK, et al. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 2011;38(3):314-9.
41. Ballantyne A, Newson A, Luna F, et al. Prenatal diagnosis and abortion for congenital abnormalities: is it ethical to provide one without the other? The American Journal of Bioethics: AJOB. 2009;9(8):48-56.
42. Chitty LS, Kagan KO, Molina FS, et al. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study. BMJ (Clinical research ed) 2006;332(7539):452-5.[Epub 2006 Feb].
43. Neilson JP, Alfirevic Z. Optimising prenatal diagnosis of Down's syndrome. BMJ (Clinical research ed) 2006;332(7539):433-4.
44. Wertz DC, Fletcher JC. Feminist criticism of prenatal diagnosis: a response. Clin Obstet Gynecol 1993;36(3):541-67.
45. Beauchamp TL, Childress JF. Principles of Biomedical Ethics (6th edn). New York: Oxford University Press; 2009.
46. Bernhardt B, Soucier D, Hanson K, et al. "It's a little bit of a black box": Patient and provider experiences with the uncertainties of prenatal microarray testing. ACMG Annual Clinical Genetics Meeting; Vancouver, Canada: American College of Medical Genetics; 2011.
47. Baillie C, Smith J, Hewison J, et al. Ultrasound screening for chromosomal abnormality: women's reactions to false positive results. Br J Health Psychol 2000;5:377-94.
48. Cristofalo EA, Dipietro JA, Costigan KA, et al. Women's response to fetal choroid plexus cysts detected by prenatal ultrasound. J Perinatol 2006;26(4):215-23.
49. Green JM, Hewison J, Bekker HL, et al. Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technol Assess (Winchester, England) 2004;8(33):iii, ix-x, 1-109.
50. Santalahti P, Latikka AM, Ryynanen M, et al. Women's experiences of prenatal serum screening. Birth 1996;23(2):101-7.
51. Jorgensen FS. User acceptability of an alpha-fetoprotein screening programme. Dan Med Bull 1995;42(1):100-5.
52. Rausch DN, Lambert-Messerlian GM, Canick JA. Participation in maternal serum screening following screen positive results in a previous pregnancy. J Med Screen 2000;7(1):4-6.
53. Kaasen A, Helbig A, Malt UF, et al. Acute maternal social dysfunction, health perception and psychological distress after ultrasonographic detection of a fetal structural anomaly. BJOG 2010;117(9):1127-38. [Epub 2010 May]
54. Ormond KE, Pergament E, Fine BA. Pre-screening education in multiple marker screening programs: the effect on patient anxiety and knowledge. J Genet Couns 1996;5(2):69-80.
55. Tercyak KP, Johnson SB, Roberts SF, et al. Psychological response to prenatal genetic counseling and amniocentesis. Patient Educ Couns 2001;43(1):73-84.
56. Bernhardt BA, Biesecker BB, Mastromarino CL. Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment. Am J Med Genet 2000;94(3):189-97.
57. Darilek S, Ward P, Pursley A, et al. Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives. Genetics in Medicine: Official Journal of the American College of Medical Genetics 2008;10(1):13-8.
58. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995;15(13):1215-26.
59. Chervenak FA, McCullough LB, Skupski D, et al. Ethical issues in the management of pregnancies complicated by fetal anomalies. Obstet Gynecol Surv 2003;58(7):473-83.
60. Sherwin S. No Longer Patient: Feminist Ethics and Health Care. Temple University Press: Philadelphia; 1992.
61. Abortion Law Reform Act, Bill No.58, 2008, State Government of Victoria, Australia.
62. Flagler E, Baylis F, Rodgers S. Bioethics for clinicians: 12. Ethical dilemmas that arise in the care of pregnant women: rethinking "maternal-fetal conflicts". CMAJ 1997;156(12):1729-32.
63. Moutard ML, Kieffer V, Feingold J, et al. Agenesis of corpus callosum: prenatal diagnosis and prognosis. Childs Nerv Syst 2003;19(7-8):471-6.
64. Furniss F, Biswas AB, Gumber R, et al. Cognitive phenotype of velocardiofacial syndrome: a review. Res Dev Disabil 2011;32(6):2206-13.
65. McGuire AL, Lupski JR. Personal genome research: what should the participant be told? Trends Genet 2010;26(5):199-201.
66. Wolf SM, Paradise J, Caga-anan C. The law of incidental findings in human subjects research: establishing researchers' duties. J Law Med Ethics 2008 Summer; 36(2):361-83, 214.
67. Benko S, Gordon CT, Mallet D, et al. Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development. J Med Genet 2011;48(12):825-30.
68. Bruno DL, Ganesamoorthy D, Schoumans J, et al. Detection of cryptic pathogenic copy number variations and constitutional loss of heterozygosity using high resolution SNP microarray analysis in 117 patients referred for cytogenetic analysis and impact on clinical practice. J Med Genet 2009;46(2):123-31.
69. Le Roux MG, Pascal O, Andre MT, et al. Non-paternity and genetic counselling. Lancet 1992;340(8819):607.
70. Lucast EK. Informed consent and the misattributed paternity problem in genetic counseling. Bioethics 2007;21(1):41-50.
71. Macintyre S, Sooman A. Non-paternity and prenatal genetic screening. Lancet 1991;338(8771):869-71.
72. Ross LF. Disclosing misattributed paternity. Bioethics 1996;10(2):114-30.
73. Elias S, Annas GJ. Generic consent for genetic screening. N Engl J Med 1994;330(22):1611-3.
74. Gillon R. Consent. Br Med J (Clin Res Ed). 1985;291(6510):1700-1.
75. Menahem S, Gillam L. Fetal diagnosis-obligations of the clinician. Case studies in the prenatal diagnosis of major heart abnormality. Fetal Diagn Ther 2007;22(3):233-7. [Epub 2007 Jan]
76. Hodgson J, Spriggs M. A practical account of autonomy: why genetic counseling is especially well suited to the facilitation of informed autonomous decision making. J Genet Couns 2005;14(2):89-97.
77. Chan A, Scott J, Nguyen A-M, et al. Pregnancy Outcome in South Australia 2005. Adelaide: Pregnancy Outcome Unit, South Australian Department of Health; 2006.
78. van Essen P, Gibson C, Scott H, et al. 2005 Annual Report of the South Australian Birth Defects Register, incorporating the 2005 Annual Report of Prenatal Diagnosis in South Australia. Adelaide. Adelaide: Children Youth and Women's Health Service2008 Contract No.: ISSN 1033-6907.
79. World Medical Association. Declaration on Therapeutic Abortion, 2006.